gracielle
Registered
- Joined
- Jun 6, 2005
- Messages
- 3,499
- Likes
- 2,842
Argentina recibirá casi 2 millones de dosis de vacuna a través de la iniciativa Covax | Lo confirmó en un comunicado la iniciativa de acceso global equitativo a los medicamentos
El país es uno de los destinos para la "primera ronda de asignaciones", por lo cual hasta mayo de este año llegarán 1.944.000 unidades de la producida por AstraZeneca-Oxford, precisó un comunicado del mecanismo liderado por la OMS y la Alianza de Vacu...
Argentina will receive almost 2 million doses of vaccine through the Covax initiative. The country is one of the destinations for the "first round of allocations", for which until May of this year 1,944,000 units of the one produced by AstraZeneca-Oxford will arrive, said a statement from the mechanism led by the WHO and the Alliance of Vaccines.
Until May, Argentina will receive almost two million doses of the coronavirus vaccine developed by AstraZeneca-Oxford as part of the Covax initiative, the mechanism that guarantees equitable global access to these drugs. The project led by the WHO and Gavi -the Vaccine Alliance-, detailed it in a statement in which they reported the list of the 142 countries that will receive the 237 million doses of vaccines developed by the University of Oxford and the AstraZeneca laboratory and 1.2 million from the Pfizer-Biontech laboratory.
"Based on current knowledge of supply availability, this first round of assignments provides information on the supply of AstraZeneca/Oxford vaccine doses to Covax Initiative participants, through May 2021," reads the text. , which specified that 1,944,000 doses will arrive in Argentina....
....The deadlines for the arrival in the country of Covax vaccines will be announced at the end of this week, although it was already anticipated that deliveries will be divided into two batches: "February-March and April-May." "These deadlines depend on a variety factors, including national regulatory requirements, availability of supply and compliance with other criteria, such as national implementation and vaccination plans, indemnification and liability agreements, and export and import authorizations, ”Covax said....
